ITGR · Insider Trading
Integer Holdings Corporation
Every open-market purchase and sale reported by ITGR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-26 | Payman Khales | President & CEO | MIXED | +1,524 | −$125.27K |
| 2026-09-16 | Kirk K Thor | Chief Human Resources Officer | Sell | −31,540 | −$3.98M |
| 2026-09-10 | Andrew Senn | President, Growth & Innovation | Sell | −9,408 | −$1.19M |
| 2026-07-10 | Milo Stephen Metcalf II | US - EVP, Operations | A | +5,424 deriv. | — |
| 2026-07-01 | Kirk K Thor | Chief Human Resources Officer | MIXED | +3,711 | −$225.12K |
| 2026-07-01 | John A Harris | President, Glob Ops & Manu Tec | A | +1,096 deriv. | — |
| 2026-05-22 | Filippo Passerini | Director | A | +1,967 | — |
| 2026-05-22 | Donald J Spence | Director | A | +2,623 deriv. | — |
| 2026-05-22 | James F. Hinrichs | Director | A | +1,967 deriv. | — |
| 2026-05-22 | Tommy P Thomas | VP, Corporate Controller | A | +666 deriv. | — |
| 2026-05-22 | Aaron Kapito | Director | A | +1,967 | — |
| 2026-05-22 | Sheila Antrum | Director | A | +1,967 | — |
| 2026-05-22 | James Francis Flanagan | Director | A | +1,967 | — |
| 2026-05-22 | Cheryl C Capps | Director | A | +1,967 | — |
| 2026-05-22 | Alvin Tyrone Jeffers | Director | A | +1,967 | — |
| 2026-05-22 | Martin C Maxwell | Director | A | +1,967 | — |
| 2026-05-22 | Michael J Coyle | Director | A | +1,967 | — |
| 2026-05-19 | Jim Stephens | President, CRM & Neuro | MIXED | +1,484 | −$42.23K |
| 2026-05-12 | Diron Smith | EVP, Chief Financial Officer | MIXED | +1,560 | −$44.32K |
| 2026-04-02 | John A Harris | EVP, Global Ops and Manufactur | MIXED | +1,995 | −$162.10K |
| 2026-03-25 | Aaron Kapito | Director | A | +410 | — |
| 2026-03-25 | James Francis Flanagan | Director | A | +410 | — |
| 2026-03-25 | Lindsay K. Blackwood | SVP, Gen Counsel & Secretary | MIXED | +2,434 | −$90.41K |
| 2026-03-25 | Terence Carr | EVP, Qlty & Regulatory Affairs | MIXED | +952 | −$34.30K |
| 2026-03-17 | Tommy P Thomas | VP, Corporate Controller | Sell | −825 | −$70.12K |
| 2026-02-24 | Diron Smith | EVP, Chief Financial Officer | MIXED | +1,221 | −$33.43K |
| 2026-02-24 | Andrew Senn | President, Cardio & Vascular | MIXED | +3,273 | −$122.78K |
| 2026-02-24 | Tommy P Thomas | VP, Corporate Controller | MIXED | +1,149 | −$60.50K |
| 2026-02-24 | Kirk K Thor | Chief Human Resources Officer | MIXED | +6,827 | −$186.50K |
| 2026-02-24 | Jim Stephens | President, CRM & Neuro | MIXED | +2,035 | −$55.66K |
| 2026-02-24 | Payman Khales | President & CEO | MIXED | +36,382 | −$1.87M |
| 2026-01-21 | Lindsay K. Blackwood | SVP, Gen Counsel & Secretary | A | +2,720 deriv. | — |
| 2026-01-21 | Terence Carr | EVP, Qlty & Regulatory Affairs | A | +1,554 deriv. | — |
| 2026-01-21 | Jim Stephens | President, CRM & Neuro | MIXED | +1,059 | −$38.34K |
| 2026-01-21 | John A Harris | EVP, Global Ops and Manufactur | MIXED | +596 | −$47.35K |
| 2026-01-21 | Kirk K Thor | Chief Human Resources Officer | MIXED | +1,466 | −$50.90K |
| 2026-01-21 | Diron Smith | EVP, Chief Financial Officer | MIXED | +2,440 | −$78.87K |
| 2026-01-21 | Tommy P Thomas | VP, Corporate Controller | MIXED | +461 | −$28.56K |
| 2026-01-21 | Andrew Senn | SVP, Strategy and Business Dev | MIXED | +2,132 | −$92.62K |
| 2026-01-21 | Payman Khales | President & CEO | MIXED | +2,607 | −$82.31K |
| 2026-01-05 | Pamela G Bailey | Director | MIXED | +1,084 | −$33 |
| 2025-12-16 | Martin C Maxwell | Director | MIXED | +969 | −$50 |
| 2025-11-13 | Tommy P Thomas | VP, Corporate Controller | Sell | −884 | −$62.01K |
| 2025-11-13 | John A Harris | EVP, Global Ops and Manufactur | Buy | +1,650 | +$115.50K |
| 2025-11-10 | Diron Smith | EVP, Chief Financial Officer | Buy | +1,115 | +$74.97K |
| 2025-11-10 | Cheryl C Capps | Director | Buy | +1,600 | +$106.72K |
| 2025-10-30 | Payman Khales | President & CEO | Buy | +3,127 | +$203.07K |
| 2025-10-27 | Payman Khales | President & CEO | A | +7,543 deriv. | — |
| 2025-07-14 | Michael J Coyle | Director | A | +1,355 | — |
| 2025-06-13 | Joseph W Dziedzic | President & CEO | MIXED | +22,807 | −$1.61M |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Payman Khales | President & CEO | 63,378 | $8.02M |
| Joseph W Dziedzic | President & CEO | 59,202 | $7.49M |
| Pamela G Bailey | Director | 56,052 | $7.09M |
| Filippo Passerini | Director | 31,114 | $3.94M |
| Martin C Maxwell | Director | 25,106 | $3.18M |
| Donald J Spence | Director | 18,781 | $2.38M |
| Cheryl C Capps | Director | 13,669 | $1.73M |
| Diron Smith | EVP, Chief Financial Officer | 13,421 | $1.70M |
| Sheila Antrum | Director | 12,069 | $1.53M |
| Margaret Carthy | EVP, Qlty & Regulatory Affairs | 10,033 | $1.27M |
| McAlister C Marshall II | SVP, Gen Counsel & Secretary | 8,672 | $1.10M |
| John A Harris | President, Glob Ops & Manu Tec | 8,657 | $1.10M |
| James F. Hinrichs | Director | 7,424 | $939.58K |
| Kirk K Thor | Chief Human Resources Officer | 7,153 | $905.28K |
| Jim Stephens | President, CRM & Neuro | 6,331 | $801.25K |
| Andrew Senn | President, Growth & Innovation | 5,405 | $684.06K |
| Alvin Tyrone Jeffers | Director | 4,552 | $576.10K |
| Tommy P Thomas | VP, Corporate Controller | 4,381 | $554.46K |
| Jean M. Hobby | Director | 3,794 | $480.17K |
| Aaron Kapito | Director | 3,337 | $422.42K |
| Michael J Coyle | Director | 3,322 | $420.43K |
| Lindsay K. Blackwood | SVP, Gen Counsel & Secretary | 2,434 | $308.05K |
| James Francis Flanagan | Director | 2,377 | $300.83K |
| Terence Carr | EVP, Qlty & Regulatory Affairs | 1,350 | $170.86K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ITGR quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.